Report Content
Chapter 1 Methodology & Scope
1.1 Market scope & definitions
1.2 Base estimates & calculations
1.3 Data collection
1.4 Forecast parameters
1.5 Data validation
1.6 Data sources
1.6.1 Primary
1.6.2 Secondary
1.6.2.1 Paid sources
1.6.2.2 Public sources
Chapter 2 Executive Summary
2.1 Industry 3600 synopsis
Chapter 3 Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Growing cases of malnutrition
3.2.1.2 High prevalence of pre-term births
3.2.1.3 Increasing prevalence of diseases, such as gastrointestinal disorder, neurological diseases, and cancer
3.2.1.4 Increasing number of surgical procedures
3.2.2 Industry pitfalls & challenges
3.2.2.1 Stringent regulatory and quality requirements
3.3 Growth potential analysis
3.4 Regulatory landscape
3.5 Porter’s analysis
3.5.1 Supplier power
3.5.2 Buyer power
3.5.3 Threat of new entrants
3.5.4 Threat of substitutes
3.5.5 Industry rivalry
3.6 PESTEL analysis
Chapter 4 Competitive Landscape, 2023
4.1 Introduction
4.2 Company matrix analysis
4.3 Company market share analysis
4.4 Competitive positioning matrix
4.5 Strategic dashboard
Chapter 5 Market Estimates and Forecast, By Type, 2018 – 2032 ($ Mn)
5.1 Key trends
5.2 Total parenteral nutrition
5.3 Peripheral parenteral nutrition
Chapter 6 Market Estimates and Forecast, By Composition, 2018 – 2032 ($ Mn)
6.1 Key trends
6.2 Carbohydrates
6.3 Vitamins & minerals
6.4 Single-dose amino acids
6.5 Parenteral lipid emulsion
6.6 Other compositions
Chapter 7 Market Estimates and Forecast, By Age Group, 2018 – 2032 ($ Mn)
7.1 Key trends
7.2 Pediatric
7.3 Adult
7.4 Geriatric
Chapter 8 Market Estimates and Forecast, By Application, 2018 – 2032 ($ Mn)
8.1 Key trends
8.2 Nutritional support
8.3 Blood transfusion
8.4 Fluid & electrolyte balance
8.5 Other applications
Chapter 9 Market Estimates and Forecast, By End-User, 2018 – 2032 ($ Mn)
9.1 Key trends
9.2 Hospitals and clinics
9.3 Ambulatory surgery centers
9.4 Home care settings
Chapter 10 Market Estimates and Forecast, By Region, 2018 – 2032 ($ Mn)
10.1 Key trends, by region
10.2 North America
10.2.1 U.S.
10.2.2 Canada
10.3 Europe
10.3.1 Germany
10.3.2 UK
10.3.3 France
10.3.4 Spain
10.3.5 Italy
10.3.6 Rest of Europe
10.4 Asia Pacific
10.4.1 Japan
10.4.2 China
10.4.3 India
10.4.4 Australia
10.4.5 South Korea
10.4.6 Rest of Asia Pacific
10.5 Latin America
10.5.1 Brazil
10.5.2 Mexico
10.5.3 Rest of Latin America
10.6 Middle East and Africa
10.6.1 South Africa
10.6.2 Saudi Arabia
10.6.3 Rest of Middle East and Africa
Chapter 11 Company Profiles
11.1 Ajinomoto Co., Inc.
11.2 Amanta Healthcare
11.3 Axa Parenterals Ltd
11.4 B. Braun Melsungen AG
11.5 Baxter International Inc.
11.6 Fresenius Kabi USA, LLC
11.7 Grifols, S.A.
11.8 ICU Medical. Inc
11.9 JW Life Science
11.10 Otsuka Pharmaceutical Co., Ltd
11.11 Pfizer, Inc.
